Advanced Medical Optics frustration after Bausch & Lomb buy-out collapses
This article was originally published in Clinica
Advanced Medical Optics has passed Bausch & Lomb into the hands of Warburg Pincus after withdrawing its $4.2bn hostile takeover bid for its eyecare rival. AMO were in the process of proving shareholder support for the takeover (see Clinica No 1267, p 12) but has subsequently broken off negotiations, citing "unrealistic hurdles that have been uniquely imposed" in a letter filed with the US Securities and Exchange Commission.
You may also be interested in...
Feature: Public Health England has revealed it is only a week away from approving a COVID-19 antibody test for distribution via Amazon. HBW Insight looks at the race to place the first, government-approved coronavirus home-test on the UK market.
As part of its efforts to preserve patient access to medicines amid the COVID-19 pandemic, Russia is planning to cap drug prices if increases of more than 30% are detected. It will also allow online sales of non-prescription drugs and may also tighten the rules on fake and substandard products.
This is an update of recommendations from the European Medicines Agency's Committee for Medicinal Products for Human Use on the authorization of new medicines in the European Union, and updates on EU marketing authorization changes recommended by the CHMP.